DekaBank Deutsche Girozentrale increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 19.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 403,194 shares of the company’s stock after purchasing an additional 64,945 shares during the quarter. DekaBank Deutsche Girozentrale owned approximately 0.28% of Henry Schein worth $26,501,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Perpetual Ltd purchased a new stake in Henry Schein in the 3rd quarter valued at about $38,000. WD Rutherford LLC purchased a new stake in Henry Schein in the 4th quarter valued at about $62,000. Chiron Capital Management LLC purchased a new stake in Henry Schein in the 3rd quarter valued at about $71,000. First Horizon Advisors Inc. grew its holdings in Henry Schein by 1,087.4% in the 4th quarter. First Horizon Advisors Inc. now owns 1,318 shares of the company’s stock valued at $88,000 after buying an additional 1,207 shares during the period. Finally, Vantage Consulting Group Inc purchased a new stake in Henry Schein in the 4th quarter valued at about $116,000. Hedge funds and other institutional investors own 94.73% of the company’s stock.
In other Henry Schein news, Director Deborah Derby bought 760 shares of the business’s stock in a transaction on Wednesday, February 24th. The shares were bought at an average cost of $66.22 per share, with a total value of $50,327.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 1.05% of the company’s stock.
Shares of NASDAQ:HSIC opened at $68.66 on Thursday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.92 and a current ratio of 1.49. Henry Schein, Inc. has a 1 year low of $49.30 and a 1 year high of $74.89. The stock has a market capitalization of $9.77 billion, a P/E ratio of 16.91, a PEG ratio of 3.12 and a beta of 0.86. The stock has a 50-day simple moving average of $65.95 and a 200-day simple moving average of $65.78.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 16th. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.99 by $0.01. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $2.86 billion. Henry Schein had a return on equity of 11.60% and a net margin of 6.14%. During the same period in the previous year, the company posted $0.97 EPS. Analysts predict that Henry Schein, Inc. will post 2.93 earnings per share for the current year.
Henry Schein Company Profile
Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Further Reading: What is the Producer Price Index (PPI)?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.